sixty-nine postmenopausal patients with advanced breast cancer were randomized to receive treatment with cyclophosphamide , methotrexate , and 5-fluorouracil ( cmf ) or ccnu , melphalan , methotrexate , and prednisone ( camp ) .
C0010583
cyclophosphamide
C0950521
cmf